Compare DSP Nifty Healthcare Index Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 0.89 | 1.87 |
NAV | ₹10.30 | ₹39.64 |
Fund Started | 02 Jun 2025 | 25 Jun 2018 |
Fund Size | ₹14.43 Cr | ₹6459.82 Cr |
Exit Load | - | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
0.89
1.87
NAV
₹10.30
₹39.64
Fund Started
02 Jun 2025
25 Jun 2018
Fund Size
₹14.43 Cr
₹6459.82 Cr
Exit Load
-
Exit load of 1% if redeemed within 15 days.
1 Year | - | 3.14% |
3 Year | - | 27.34% |
5 Year | - | 17.86% |
1 Year
-
3.14%
3 Year
-
27.34%
5 Year
-
17.86%
Equity | 99.72% | 97.70% |
Cash | 0.28% | 2.30% |
Equity
99.72%
97.70%
Cash
0.28%
2.30%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 19.16% |
Max Healthcare Institute Ltd. | 8.58% |
Cipla Ltd. | 8.55% |
Divi's Laboratories Ltd. | 8.17% |
Dr. Reddy's Laboratories Ltd. | 7.61% |
Apollo Hospitals Enterprise Ltd. | 7.36% |
Lupin Ltd. | 5.00% |
Fortis Healthcare Ltd. | 4.76% |
Laurus Labs Ltd. | 3.98% |
Torrent Pharmaceuticals Ltd. | 3.86% |
Sun Pharmaceutical Industries Ltd. | 12.83% |
Dr. Reddy's Laboratories Ltd. | 9.81% |
Cipla Ltd. | 8.00% |
Divi's Laboratories Ltd. | 7.48% |
Aurobindo Pharma Ltd. | 6.04% |
Lupin Ltd. | 5.70% |
Mankind Pharma Ltd. | 5.04% |
Alkem Laboratories Ltd. | 3.78% |
Syngene International Ltd. | 2.97% |
Cohance Lifesciences Ltd. | 2.68% |
Name | Anil Ghelani | Dharmesh Kakkad |
Start Date | 24 Nov 2025 | 23 Feb 2021 |
Name
Anil Ghelani
Dharmesh Kakkad
Start Date
24 Nov 2025
23 Feb 2021
Description | The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 02 Jun 2025 | 25 Jun 2018 |
Description
The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
02 Jun 2025
25 Jun 2018